Gryphon licenses NCL patents to IVGN

Invitrogen (IVGN) received a non-exclusive sublicense from Gryphon (South San Francisco, Calif.) to patents covering Native Chemical Ligation (NCL) technology for synthesizing proteins using chemical ...